Molecule Structure

Scientific Name


Description of the Drug

Canrenone is an antimineralocorticoid and active metabolite of spironolactone used in the treatment of primary hyperaldosteronism and edematous states caused by secondary hyperaldosteronism (e.g. heart failure).

Source: DrugBank Online – Retrieved 2023-03-10 from

Brand Name(s)

Not Available

Company Owner(s)

Not Available

Mechanism(s) Of Action

Target Name Target Type Action Type Target ChEMBL ID
Mineralocorticoid receptor SINGLE PROTEIN ANTAGONIST CHEMBL1994

Unichem Links

Human Metabolome Database HMDB0003033
DrugBank DB12221
PubChem: Thomson Pharma 14875687 14851493
PubChem 13789
Mcule MCULE-8218872905
Nikkaji J7.205B
EPA CompTox Dashboard DTXSID3045930
DrugCentral 478
Brenda 59425
ChemicalBook CB0147626
ChEBI 135445
ZINC ZINC000003881648